Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, α-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-pep...
Saved in:
Main Authors: | Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2025.2460045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01) -
Perspectives on additive manufacturing for warhead applications
by: Hao Xue, et al.
Published: (2025-01-01) -
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01) -
Chemical reactivity of alliin and its molecular interactions with the M proteasepro of SARS-CoV-2
by: López-Orozco Wendolyne, et al.
Published: (2024-01-01) -
Covalent Organic Frameworks for Membrane Separation
by: Yuan‐Hang Jin, et al.
Published: (2025-02-01)